AstraZeneca’s Chennai-based GTC sees strong growth and momentum
In 2016, the centre will focus a lot on application development and testing, business intelligence and analytics, mobility and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Natco Pharma to sell US-based pharmacy stores
Financial details were not disclosed as well as reasons for sale of the assets
Gujarat State TB Association, Sparsh and Cadila Pharma organise medical camps
Awareness was raised on tuberculosis where more than 300 villagers underwent health checkups and were given consultations
Videojet launches Pharma Hub web portal
The hub will provide pharma and medical device manufacturers with reliable and comprehensive source of information
Lupin clarifies on from 483s issued by US FDA for its Mandideep facility
The company believes that the observations are minor in nature and have been already addressed
Govt’s decision to ban 344 FDCs was taken without consideration: Pharma cos to Delhi HC
The government will advance arguments after the pharma companies make their submissions
Sun Pharma enters Japanese prescription market
Acquires 14 prescription brands
Sun Pharma has acquired 14 established prescription brands from Novartis in Japan. According to…
Jubilant Innovation USA to receive up to $22.6 m over acquisition of drug development firm
The payments are on account of an acquisition by a large pharma company of one of their investee companies having assets in early…
Cadila gets US FDA nod to sell generic anti-viral drug
The drugs will be manufactured in Ahmedabad
Aurobindo Pharma receives US FDA approval for rivastigmine tartrate capsules
The product is expected to be launched in Q1 FY16-17
Zydus acquires gastro therapy ‘Actibile’ from Albert David
Strengthens its presence in the gastroenterology segment
Zydus Healthcare, a wholly-owned subsidiary of Cadila Healthcare has…
Panacea Biotec launches CABAPAN
CABAPAN is a cost effective product for the treatment of metastatic castration resistant prostrate cancer
Biocon’s Insulin Glargine receives regulatory approval in Japan
The product is ready to be launched in Q1 FY17
DRL in agreement with XenoPort
DRL will be granted exclusive US rights for the development and commercialisation of XenoPort’s clinical-stage oral new chemical…
Glenmark receives US FDA approval for bendamustine hydrochloride injection
It is Glenmark’s first injectable approval in the US
Cadila Pharma initiates awareness campaigns to observe ‘World TB Day’
Multi-city patient awareness programmes, free diagnosis, rallies, radio, street play and film activity has been planned to raise…
MSF welcomes Ministry of Commerce clarification on Compulsory Licensing
Warns US pressure on India will continue
The Ministry of Commerce recently clarified that media reports claiming that the…
Torrent Pharma seeks shareholder approval for equity raise and borrowing plans
The move will help the company to take quick and effective actions to capitalise on opportunities
Sun Pharma partners with AstraZeneca India over Type II diabetes medicine
Under the agreement, Sun Pharma will promote and distribute dapagliflozin under the brand name 'Oxra'
SDI, FICCI & Express Pharma discuss ‘Innovation & International Competitiveness’
The roundtable explored opportunities in life sciences that India and Scotland can leverage to complement each other